Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mineral oil cationic nanoemulsion vs perfluorohexyloctane on tear film lipid layer and aberrations
DRKS00028696Phase 4Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Apr 2022
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of cationorm and perfluorohexyloctane in dacryoadenitis and dry eye syndrome (DED) (6 arms), sponsored by Heinrich Heine University Düsseldorf. Primary endpoints: Change in tear film lipid layer and Change in higher order aberrations. Started Apr 2022; status: completed.
02
Drugs
cationormperfluorohexyloctane
03
Conditions
dacryoadenitisdry eye syndrome (DED)
Beyond the preview
Go deeper on DRKS00028696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00028696.